GlassScriptPhysician profile
Daniel L Kollwitz
NPI 1225196819
$4,221.17
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,056 · 2022: $898 · 2023: $1,380 · 2024: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,266.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,056.69 | 2021-2024 | Stelara, Simponi Aria, Remicade |
| Abbvie INC. | $733.35 | 2021-2024 | |
| Qol Medical, LLC | $645.51 | 2021-2024 | Sucraid, Sucraid |
| Genzyme Corporation | $463.90 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $249.98 | 2021-2024 | Eohilia, Gattex |
| Ipsen Biopharmaceuticals, INC | $185.92 | 2023-2024 | Bylvay |
| Nestle Healthcare Nutrition INC. | $171.21 | 2021-2023 | |
| Amgen INC. | $143.65 | 2021-2023 | Avsola, Amjevita |
| Painteq LLC | $115.73 | 2023 | Painteq |
| Regeneron Healthcare Solutions, INC. | $80.69 | 2022-2024 | Dupixent |
| Travere Therapeutics, INC. | $80.49 | 2022-2023 | Cholbam |
| Mirum Pharmaceuticals, INC. | $77.79 | 2023-2024 | Livmarli |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.59 | 2023 | Cyltezo |
| Alfasigma USA, INC. | $49.52 | 2021-2022 | |
| Albireo Pharma, INC. | $40.79 | 2023 | Bylvay |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $34.94 | 2021-2023 | Immunocap |
| Medtronic, INC. | $13.42 | 2023 | Inpen Smart Insulin Delivery System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kollwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.